Reading the tape
NYSE: ABBV
AbbVie Inc.
Healthcare · Drug Manufacturers - General
Market Cap
$365.43B
52w High
$244.81
52w Low
$176.57
P/E
100.71
Volume
5.34M
Outstanding Shares
1.77B
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
1Y Price: 6.86%Revenue (TTM): 9.5%FCF (TTM): 4.87%P/FCF: 92nd pct
What changed
The stock rose 6.86% over the last year. Revenue grew 9.5% over the trailing twelve months. Operating margin moved from 17.56% to 27.6%. Free cash flow grew 4.87% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 27.6%. A decisive move in revenue — currently up 9.5% — would be the clearest signal to resolve the ambiguity.
Company profile
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.
CEORobert A. Michael
SectorHealthcare
IndustryDrug Manufacturers - General
Employees55,000
IPO dateJan 2, 2013
Valuation
Forward P/E—
EV/EBITDA26.70
Enterprise value$470.64B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth12.43%
Gross margin73.46%▲0.35%vs FY2024
Operating margin27.6%▲102.54%vs FY2024
ROE-129.24%▼200.45%vs FY2024
Analyst consensus
RatingBuy
Target price$256.69▲24.24%
28
Buy
12
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 30, 2026
Q3 FY26 · EPS est $3.73 · Revenue est $16.78B
View
Dividends
$6.74/shareQuarterlyDividend Achiever · 12yrAt RiskABBV pays a dividend with a 3.26% dividend yield, 12 consecutive years of growth, growing at 6.33% annually, covered 1.5× by free cash flow.
Dividend Yield
3.26%
Annual Div / Share
$6.74
5yr CAGR
+6.33%
Doubles every ~11.3yr
Payout Ratio
320.34%
At Risk
Dividend Growth Rate
3yr CAGR
+5.26%
5yr CAGR
+6.33%
10yr CAGR
+12.05%
Dividend Safety
5/10At Risk
Dividend History
Annualized dividend cycles per share
YearAnnual DivYoY
2026$6.74+5.6%
2025$6.38+5.3%
2024$6.06+4.8%
2023$5.78+6.6%
2022$5.42+9.3%
2021$4.96+10.2%
2020$4.50+10.8%
Income Projection
Invest
$
Growth rate:
Reinvest dividends
Today
$33/yr
$3/mo
In 5 yrs
$44/yr+36%
$4/mo
In 10 yrs
$60/yr+85%
$5/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$33/yr $3/mo | $44/yr+36% $4/mo | $60/yr+85% $5/mo |
Yield-on-cost grows from 3.26% → 6.02% over 10yr
Analysis
Dividend Strengths
Dividend Achiever
ABBV has raised its dividend for 12 consecutive years — qualifying as a Dividend Achiever, demonstrating long-term commitment to shareholder income.
Well-covered by free cash flow
The dividend is covered 1.5× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Strong dividend growth rate
The 5-year CAGR of 6.33% meaningfully outpaces inflation, compounding real income growth for long-term holders.
Risks to Watch
High payout ratio
With 320.34% of earnings paid as dividends, there is limited retained earnings for reinvestment — and a dividend cut becomes more likely if earnings decline.